⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfamate SCHEMBL2545884 | 1.00 | CA1 (1.00) | — | |
| Sulfamate SCHEMBL11400 | 1.00 | — | — | |
| Sulfamate SCHEMBL11497736 | 0.94 | — | — | |
| Sulfamate SCHEMBL3145080 | 0.94 | — | — | |
| Sulfamate SCHEMBL15209916 | 0.94 | CA1 (0.89) | — | |
| Sulfamate SCHEMBL23581784 | 0.94 | — | — | |
| Sulfamate SCHEMBL20874504 | 0.94 | — | — | |
| Sulfamate SCHEMBL20658932 | 0.94 | — | — | |
| Sulfamate SCHEMBL21641875 | 0.94 | — | — | |
| Sulfamate SCHEMBL23498394 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190283010-A1 | EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS | EMPIRIKO CORPORATION | 2019-09-19 | — | — | US | disclosed |
| US-10265692-B2 | Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds | EMPIRIKO CORPORATION (US) | 2019-04-23 | — | — | US | disclosed |
| US-9580749-B2 | Dyes and labeled molecules | BIOTIUM, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160303553-A1 | EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS | EMPIRIKO CORPORATION | 2016-10-20 | — | — | US | disclosed |
| US-9102835-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2015-08-11 | — | — | US | disclosed |
| WO-2015089089-A1 | EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS | EMPIRIKO CORPORATION (US) | 2015-06-18 | — | — | WO | disclosed |
| US-20150038688-A1 | USE OF METALLOPORPHYRINS AND SALEN COMPLEXES FOR THE CATALYTIC OXIDATION OF ORGANIC COMPOUNDS | Thinq Pharma | 2015-02-05 | — | — | US | disclosed |
| US-8877437-B1 | Methods of using dyes in association with nucleic acid staining or detection | BIOTIUM, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8753814-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20140106349-A1 | Dyes and Labeled Molecules | ALLELOGIC BIOSCIENCES CORPORATION (US) | 2014-04-17 | — | — | US | disclosed |
| US-20060211028-A1 | Dimeric and trimeric nucleic acid dyes, and associated systems and methods | ALLELOGIC BIOSCIENCES CORPORATION | 2006-09-21 | — | — | US | disclosed |
| US-20060211029-A1 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006099605-A2 | DIMERIC AND TRIMERIC NUCLEIC ACID DYES, AND ASSOCIATED SYSTEMS AND METHODS | BIOTIUM, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| EP-0992513-B1 | Isolated metallopeptide: compositions and synthetic methods | SCRIPPS RESEARCH INST (US) | 2002-12-18 | — | — | EP | disclosed |
| EP-0992513-A2 | Isolated metallopeptide: compositions and synthetic methods | THE SCRIPPS RESEARCH INSTITUTE (US) | 2000-04-12 | — | — | EP | disclosed |
| EP-0552284-B1 | ISOLATED METALLOPOLYPEPTIDE: COMPOSITIONS AND SYNTHETIC METHODS | SCRIPPS RESEARCH INST (US) | 2000-03-29 | — | — | EP | disclosed |
| US-5408036-A | A polyvalent ion covalently linked to 2 to 8 polypeptide binding ligands, each of which covalently bonded to a linear polypeptide | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-04-18 | — | — | US | disclosed |
| EP-0552284-A4 | — | — | 1994-03-23 | — | — | EP | disclosed |
| EP-0552284-A1 | ISOLATED METALLOPOLYPEPTIDE: COMPOSITIONS AND SYNTHETIC METHODS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-07-28 | — | — | EP | disclosed |
| WO-1992006110-A1 | ISOLATED METALLOPOLYPEPTIDE: COMPOSITIONS AND SYNTHETIC METHODS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1992-04-16 | — | — | WO | disclosed |